Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

Bonneterre, Jacques; Thürlimann, Beat; Robertson, J.F.R.; Krzakowski, Maciej; Mauriac, L.; Koralewski, P.; Vergote, Ignace; Webster, Alan; L. Steinberg, Mark; von Euler, Mia

doi:10.1200/jco.2000.18.22.3748

Public

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

Published in Journal of Clinical Oncology • Nov 15, 2000

Authors:

Jacques Bonneterre

Beat Thürlimann

J.F.R. Robertson

Abstract

PURPOSE: To compare the efficacy and tolerability of anastrozole (Arimidex; AstraZeneca, Wilmington, DE, and Macclesfield, United Kingdom) with that of tamoxifen as first-line therapy for advanced breast cancer (ABC) in postmenopausal women. PATIENTS AND METHODS: This randomized, double-blind, multi...

Subject

Anastrozole

Tamoxifen

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!